[Canine leishmaniasis in Spain: data for the clinician].
Ferrer
L
L
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D015331:Cohort Studies; D004197:Disease Reservoirs; D004283:Dog Diseases / Q000188:drug therapy / Q000453:epidemiology*; D004285:Dogs; D005065:Euthanasia / Q000662:veterinary; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000662:veterinary*; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D013030:Spain / Q000453:epidemiology
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate
Leishmaniosis canina en España: datos para el clínico.